1. VALUE: New-onset diabetes in an amlodipine-based vs valsartan-based therapy in high-risk hypertensives
Diagnostic criteria
Valsartan n (%)
Amlodipine n (%)
Odds ratio (95% CI) p
Adverse event reports, new antidiabetic medication, and/or fasting glucose >7.0 mmol/L
580 (11.5)
718 (14.5)
0.77
( )
<0.0001
New antidiabetic medication and/or fasting glucose >7.0 mmol/L
495 (9.8)
586 (11.8)
0.82
( )
0.0015
Jamerson KA. American Hypertension Society 20th Annual Scientific Session; May 14-18, 2005; San Francisco, CA.